Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one

  1. Gonçalves, J.
  2. Santos, C.D.
  3. Fresco, P.
  4. Fernandez-Llimos, F.
Revue:
Revista Portuguesa de Cardiologia

ISSN: 2174-2030,  0870-2551

Année de publication: 2024

Volumen: 43

Número: 4

Pages: 221-222

Type: Lettre

DOI: 10.1016/J.REPC.2023.10.005 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus